Source: Medical Product Outsourcing

Cordis: FDA Approves Cordis' Mynx Control Venous Vascular Closure Device

According to the company, MYNX Control's sealant resorbs three times faster than collagen-based sealants.

Read full article »
Est. Annual Revenue
$500M-1.0B
Est. Employees
1.0-5.0K
Scott Drake's photo - CEO of Cordis

CEO

Scott Drake

CEO Approval Rating

82/100

Read more